Clinical trial
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
NCT00313924 · Rambam Health Care Campus, Other · Unknown status
Key facts
| NCT number | NCT00313924 |
|---|---|
| Title | Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome |
| Official title | The Applicability of the OAB Assessment Tool for Evaluation of Treatment Efficacy of Overactive Bladder. |
| Lead sponsor | Rambam Health Care Campus, Other |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Overactive Bladder |
| Intervention type | Drug |
| Interventions | DETRUSITOL |
| Enrollment | 100 |
| Start date | Feb 1, 2006 |
| Completion | Mar 1, 2006 |
| First posted | Apr 12, 2006 |
| Last update posted | Feb 21, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: